Dishman Pharma

• 

  Dishman Pharma Surges Nearly 40% In Two Sessions

  Shares of Dishman Pharma came in huge demand in opening deals in today's session. On Bombay Stock Exchange alone 1.52 million shares changed hands.

• 

  Buy Lakshmi Machine Works, JBM Auto: Jay Thakkar

  The Nifty has broken out after a month-long consolidation, on the back of good volumes, said Jay Thakkar, senior technical analyst, at Sharekhan. The Nifty should go up to levels of 8,850, he added.

• 

  GM Breweries Could Rally Like Tata Metaliks: Jai Bala

  Correction in Nifty towards 8,300-8,400 levels will be healthy but investors should not trade Nifty on the short side as major trend is still up for the markets, says market expert Jai Bala.

• 

  Dishman Pharma Posts 14% Rise In June Quarter Profit

  Dishman Pharmaceuticals and Chemicals on Wednesday posted a 13.7 per cent rise in consolidated net profit at Rs 45.5 crore for the quarter ended June.

• 

  Dishman Pharma Gets Inspection Report For 3 Sites From US Regulator

  Dishman Pharmaceuticals and Chemicals has received an establishment inspection report (EIR) from the US Food and Drug Administration (FDA) for three of its facilities.

• 

  Dishman Pharma Surges On Completion Of FDA Inspection of Gujarat Facility

  Dishman Pharmaceuticals and Chemicals shares gained as much as 9 per cent to touch a day's high of Rs 149 after the company announced that the inspection at its Bavla facility in Gujarat has been successfully completed by US Food and Drug Regulator.

• 

  Dishman Q4 Net Profit Up 29% At Rs 50 Crore

  Dishman Pharmaceuticals and Chemicals on Thursday reported a 29.29 per cent increase in consolidated net profit at Rs 49.92 crore for the March quarter.

• 

  Dishman Pharma Climbs 4% On Fixing Record Date For Bonus Issue

  Dishman Pharma's scrip rose by over 4 per cent today after the company fixed May 3 as record date for bonus shares.

• 

  Dishman Pharma Posts Two-Fold Rise in Q3 Profit

  Dishman Pharmaceuticals and Chemicals on Friday reported a nearly two-fold jump in consolidated net profit to Rs 46.93 crore for the quarter ended December 31, 2015.

• Dishman Pharma Posts 9% Rise in Q2 Profit

  Dishman Pharmaceuticals and Chemicals on Thursday reported a 9.44 per cent rise in consolidated net profit at Rs 36.50 crore for the fiscal second quarter that ended on September 30, 2015.

• 

  Dishman Shares Surge 25% in 3 Days on Strong Earnings

  Dishman Pharma shares have nearly doubled in last three months compared to 5 per cent loss in the broader Nifty.

• Why Dishman Pharma is Up 90% in a Year

  Dishman primarily provides outsourcing services for Active Pharmaceutical Ingredients (API) to large pharma companies and help them in commercialisation of those products.

• Dishman Pharma Posts 21.5 Per Cent in March Quarter Profit

  Dishman Pharmaceuticals and Chemicals on Wednesday reported a 21.5 per cent increase in net profit at Rs 22.56 crore for the quarter ended March, 2014.

• Dishman Pharma & Chemicals Q2 loss at Rs 6.33 cr, stock down 5%

  Dishman Pharmaceuticals and Chemicals Ltd has announced its second quarter results for the current fiscal. The company’s net loss for the second quarter ended September 30, 2011 stood at Rs 6.33 crore against Rs 28.29 crore for the quarter ended September 30, 2010. Its net sales stood at Rs 269.20 crore for the second quarter this ...

• Australian nod for unit boosts Dishman Pharma

  The government on Friday said direct tax collection has surpassed the budget estimate of Rs 3.70 lakh crore for the 2010 fiscal.